Development of NSAIDs with lower gastric side effect

Tohru Mizushima

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The anti-inflammatory action of nonsteroidal anti-inflammatory drugs (NSAIDs) is mediated through their inhibitory effects on cyclooxygenase (COX) activity. On the other hand, NSAIDs use is associated with gastrointestinal complications. The inhibition of COX by NSAIDs is not the sole explanation for the gastrointestinal side effects of NSAIDs. In this article, I review our recent work on the COXindependent mechanism involved in NSAID-induced gastric lesions. Using DNA microarray analysis, we found that NSAIDs affect expression of various genes in a COX-independent manner and found that membrane permeabilization activity of NSAIDs and resulting NSAID-induced apoptosis are involved in NSAID-induced gastric lesions. These results suggest that NSAIDs with lower membrane permeabilization activity would be safer on stomach tissue and we found that loxoprofen, a clinically used NSAID, has relatively lower membrane permeabilization activity than other NSAIDs. We synthesized derivatives of loxoprofen and found that fluoro-loxoprofen has lower membrane permeabilization activity and their oral administration produced fewer gastric lesions but showed an equivalent anti-inflammatory effect. These results suggest that fluoro-loxoprofen is likely to be therapeutically beneficial as safer NSAIDs.

Original languageEnglish
Title of host publicationCell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment
PublisherS. Karger AG
Pages71-78
Number of pages8
Volume30
ISBN (Print)9783318021844, 9783318021837
DOIs
Publication statusPublished - 2012 Jun 22

Fingerprint

Stomach
Anti-Inflammatory Agents
Pharmaceutical Preparations
Prostaglandin-Endoperoxide Synthases
Membranes
Gastrointestinal Agents
Microarray Analysis
Microarrays
Oligonucleotide Array Sequence Analysis
Oral Administration
Genes
Tissue
Apoptosis
Derivatives
Gene Expression

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Mizushima, T. (2012). Development of NSAIDs with lower gastric side effect. In Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment (Vol. 30, pp. 71-78). S. Karger AG. https://doi.org/10.1159/000338396

Development of NSAIDs with lower gastric side effect. / Mizushima, Tohru.

Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment. Vol. 30 S. Karger AG, 2012. p. 71-78.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mizushima, T 2012, Development of NSAIDs with lower gastric side effect. in Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment. vol. 30, S. Karger AG, pp. 71-78. https://doi.org/10.1159/000338396
Mizushima T. Development of NSAIDs with lower gastric side effect. In Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment. Vol. 30. S. Karger AG. 2012. p. 71-78 https://doi.org/10.1159/000338396
Mizushima, Tohru. / Development of NSAIDs with lower gastric side effect. Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment. Vol. 30 S. Karger AG, 2012. pp. 71-78
@inbook{b90d2e4a52a940ef8a8e09aea142874b,
title = "Development of NSAIDs with lower gastric side effect",
abstract = "The anti-inflammatory action of nonsteroidal anti-inflammatory drugs (NSAIDs) is mediated through their inhibitory effects on cyclooxygenase (COX) activity. On the other hand, NSAIDs use is associated with gastrointestinal complications. The inhibition of COX by NSAIDs is not the sole explanation for the gastrointestinal side effects of NSAIDs. In this article, I review our recent work on the COXindependent mechanism involved in NSAID-induced gastric lesions. Using DNA microarray analysis, we found that NSAIDs affect expression of various genes in a COX-independent manner and found that membrane permeabilization activity of NSAIDs and resulting NSAID-induced apoptosis are involved in NSAID-induced gastric lesions. These results suggest that NSAIDs with lower membrane permeabilization activity would be safer on stomach tissue and we found that loxoprofen, a clinically used NSAID, has relatively lower membrane permeabilization activity than other NSAIDs. We synthesized derivatives of loxoprofen and found that fluoro-loxoprofen has lower membrane permeabilization activity and their oral administration produced fewer gastric lesions but showed an equivalent anti-inflammatory effect. These results suggest that fluoro-loxoprofen is likely to be therapeutically beneficial as safer NSAIDs.",
author = "Tohru Mizushima",
year = "2012",
month = "6",
day = "22",
doi = "10.1159/000338396",
language = "English",
isbn = "9783318021844",
volume = "30",
pages = "71--78",
booktitle = "Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment",
publisher = "S. Karger AG",

}

TY - CHAP

T1 - Development of NSAIDs with lower gastric side effect

AU - Mizushima, Tohru

PY - 2012/6/22

Y1 - 2012/6/22

N2 - The anti-inflammatory action of nonsteroidal anti-inflammatory drugs (NSAIDs) is mediated through their inhibitory effects on cyclooxygenase (COX) activity. On the other hand, NSAIDs use is associated with gastrointestinal complications. The inhibition of COX by NSAIDs is not the sole explanation for the gastrointestinal side effects of NSAIDs. In this article, I review our recent work on the COXindependent mechanism involved in NSAID-induced gastric lesions. Using DNA microarray analysis, we found that NSAIDs affect expression of various genes in a COX-independent manner and found that membrane permeabilization activity of NSAIDs and resulting NSAID-induced apoptosis are involved in NSAID-induced gastric lesions. These results suggest that NSAIDs with lower membrane permeabilization activity would be safer on stomach tissue and we found that loxoprofen, a clinically used NSAID, has relatively lower membrane permeabilization activity than other NSAIDs. We synthesized derivatives of loxoprofen and found that fluoro-loxoprofen has lower membrane permeabilization activity and their oral administration produced fewer gastric lesions but showed an equivalent anti-inflammatory effect. These results suggest that fluoro-loxoprofen is likely to be therapeutically beneficial as safer NSAIDs.

AB - The anti-inflammatory action of nonsteroidal anti-inflammatory drugs (NSAIDs) is mediated through their inhibitory effects on cyclooxygenase (COX) activity. On the other hand, NSAIDs use is associated with gastrointestinal complications. The inhibition of COX by NSAIDs is not the sole explanation for the gastrointestinal side effects of NSAIDs. In this article, I review our recent work on the COXindependent mechanism involved in NSAID-induced gastric lesions. Using DNA microarray analysis, we found that NSAIDs affect expression of various genes in a COX-independent manner and found that membrane permeabilization activity of NSAIDs and resulting NSAID-induced apoptosis are involved in NSAID-induced gastric lesions. These results suggest that NSAIDs with lower membrane permeabilization activity would be safer on stomach tissue and we found that loxoprofen, a clinically used NSAID, has relatively lower membrane permeabilization activity than other NSAIDs. We synthesized derivatives of loxoprofen and found that fluoro-loxoprofen has lower membrane permeabilization activity and their oral administration produced fewer gastric lesions but showed an equivalent anti-inflammatory effect. These results suggest that fluoro-loxoprofen is likely to be therapeutically beneficial as safer NSAIDs.

UR - http://www.scopus.com/inward/record.url?scp=84925849374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925849374&partnerID=8YFLogxK

U2 - 10.1159/000338396

DO - 10.1159/000338396

M3 - Chapter

SN - 9783318021844

SN - 9783318021837

VL - 30

SP - 71

EP - 78

BT - Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment

PB - S. Karger AG

ER -